Template:Infant fever well antibiotics: Difference between revisions

(Created page with "{| {{table}} | align="center" style="background:#f0f0f0;"|'''Suspected Infection Source''' | align="center" style="background:#f0f0f0;"|'''8-21 Days Old''' | align="center" style="background:#f0f0f0;"|'''22-28 Days Old''' | align="center" style="background:#f0f0f0;"|'''29-60 Days Old''' |- | UTI|| *Ampicillin IV or IM (150 mg/kg per day divided q8) AND either: **Ceftazidime IV or IM (150 mg/kg per day divided q8) or **Gentamicin IV or IM (4 mg/kg per do...")
 
No edit summary
Line 1: Line 1:
===Pediatric Antibiotics by Source<ref>Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228 </ref>===
{| {{table}}
{| {{table}}
| align="center" style="background:#f0f0f0;"|'''Suspected Infection Source'''
| align="center" style="background:#f0f0f0;"|'''Suspected Infection Source'''
Line 40: Line 41:
*AND [[Vancomycin]] IV (60 mg/kg QD)
*AND [[Vancomycin]] IV (60 mg/kg QD)
|}
|}
''source''<ref>Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228 </ref>

Revision as of 15:39, 30 July 2025

Pediatric Antibiotics by Source[1]

Suspected Infection Source 8-21 Days Old 22-28 Days Old 29-60 Days Old
UTI
  • Ampicillin IV or IM (150 mg/kg per day divided q8) AND either:
No source identified
  • Ampicillin IV or IM (150 mg/kg per day divided q8) AND either:
Bacterial meningitis
  • Ampicillin IV or IM (300 mg/kg per day divided q6) AND
  • Ceftazidime IV or IM (150 mg/kg per day divided q8)
  • Ampicillin IV or IM (300 mg/kg per day divided q6) AND
  • Ceftazidime IV or IM (150 mg/kg per day divided q8)
  1. Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228